Millennium Medical Publishing, Inc

SHERPA: Unknown

People

  1. Chaft
    Chaft
  2. Adusumilli
    Adusumilli
  3. Argiles Martinez
    Argiles Martinez
  4. Cercek Hanjis
    Cercek Hanjis
  5. Danila
    Danila
  6. Grimm
    Grimm
  7. Morris
    Morris
  8. Rosenberg
    Rosenberg
  9. Schram
    Schram
  10. Stein
    Stein

Groups

  1. Department of Medicine (10)
  2. Solid Tumor Oncology Division (7)
  3. Center for Hematologic Malignancies (3)
  4. Genitourinary Oncology Service (3)
  5. Hematologic Malignancies, Division of (3)
  6. Adult Leukemia (2)
  7. GSK Faculty (2)
  8. Sloan Kettering Institute Faculty (2)
  9. Thoracic Oncology (2)
  10. Body Imaging Service (1)
Search Within
  1. "Miscellaneous"
Formats
  1. Miscellaneous (15)
Groups
  1. Department of Medicine (10)
  2. Solid Tumor Oncology Division (7)
  3. Center for Hematologic Malignancies (3)
  4. Genitourinary Oncology Service (3)
  5. Hematologic Malignancies, Division of (3)
  6. Adult Leukemia (2)

More Groups

People
  1. Jamie Chaft (2)
  2. Alison Schram (1)
  3. Andrea Cercek Hanjis (1)
  4. Anthony Mato (1)
  5. Connie Batlevi (1)
  6. Daniel Danila (1)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2022 (2)
  4. 2021 (4)
  5. 2020 (5)
Publications
  1. Clinical Advances in Hematology & Oncology (15)

Results (15)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Treatment deintensification in locally advanced rectal cancer: When less is more [Interview]
    Miscellaneous

    Cercek, A.
    Clinical Advances in Hematology & Oncology (2025)

    Fulltext@MSK | Save
  • The use of zenocutuzumab for NRG1 fusion–positive tumors [Interview]
    Miscellaneous

    Schram, A.
    Clinical Advances in Hematology & Oncology (2024)

    Fulltext@MSK | Save
  • Targeted therapy in prostate cancer: Beyond PSMA [Interview]
    Miscellaneous

    Morris, M. J.
    Clinical Advances in Hematology & Oncology (2024)

    Fulltext@MSK | Save
  • Can unresectable non-small cell lung cancer become resectable? [Interview]
    Miscellaneous

    Chaft, J. E.
    Clinical Advances in Hematology & Oncology (2024)

    Fulltext@MSK | Save
  • Prevention and treatment of venous thromboembolism in primary and metastatic brain cancer
    Miscellaneous

    Zwicker, J.
    Clinical Advances in Hematology & Oncology (2022)

    Fulltext@MSK | Save
  • Optimizing administration of third-line treatment in metastatic colorectal cancer: Q&A
    Miscellaneous

    Prager, G. W.; Argilés, G.
    Clinical Advances in Hematology & Oncology (2022)

    Fulltext@MSK | Save
  • Neoadjuvant and adjuvant approaches in surgically resectable NSCLC [Interview]
    Miscellaneous

    Chaft, J. E.
    Clinical Advances in Hematology & Oncology (2021)

    Fulltext@MSK | Save
  • IDH inhibitors in acute myeloid leukemia and myelodysplastic syndrome [Interview]
    Miscellaneous

    Stein, E. M.
    Clinical Advances in Hematology & Oncology (2021)

    Fulltext@MSK | Save
  • Chimeric antigen receptor T-cell therapy plus checkpoint blockade in thoracic cancers [Interview]
    Miscellaneous

    Adusumilli, P. S.
    Clinical Advances in Hematology & Oncology (2021)

    Fulltext@MSK | Save
  • New treatments for patients with progressive metastatic urothelial carcinoma [Interview]
    Miscellaneous

    Rosenberg, J. E.
    Clinical Advances in Hematology & Oncology (2021)

    Fulltext@MSK | Save

    • Millennium Medical Publishing, Inc – authorized name for: